Affinity Asset Advisors, LLC Centessa Pharmaceuticals PLC Transaction History
Affinity Asset Advisors, LLC
- $560 Million
- Q4 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 1,095,924 shares of CNTA stock, worth $17.9 Million. This represents 3.28% of its overall portfolio holdings.
Number of Shares
1,095,924
Previous 965,612
13.5%
Holding current value
$17.9 Million
Previous $15.4 Million
18.89%
% of portfolio
3.28%
Previous 2.67%
Shares
15 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$326 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$163 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$158 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$104 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$94.8 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.54B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...